Nutrient and hormone composition of milk is altered in rodent dams post-bariatric surgery.
Evangeline M DeerBradley WelchLaura L HernandezRandy J SeeleyBernadette E GraysonPublished in: Journal of developmental origins of health and disease (2019)
Although bariatric surgery is approved for a woman of child-bearing age with an interest in subsequent pregnancy, reports of in utero growth issues during pregnancy have garnered a closer look at the impact of maternal surgical weight loss on the pre- and postpartum periods. Offspring of dams having received vertical sleeve gastrectomy (VSG) are born small-for-gestational age and have increased risk for metabolic syndrome later in life. Here, we aimed to determine whether the postnatal catch-up growth trajectory of bariatric offspring may be affected by milk composition. Milk samples were collected at postnatal day 15/16 from dams having received VSG surgery and fed a high-fat diet (HFD) (H-VSG), Sham surgery and fed chow (C-Sham), or Sham surgery and fed HFD (H-Sham). Milk obtained from H-VSG dams had elevated glucose (P < 0.05) and significantly reduced triglyceride content (P < 0.01). Milk from H-Sham dams had the lowest amount of milk protein (P < 0.05). Fatty acid composition measured by fractionation was largely not affected by surgery but rather maternal diet. No difference was observed in milk leptin levels; however, insulin, adiponectin, and growth hormone levels were significantly increased in milk from H-VSG animals. H-Sham had the lowest level of immunoglobulin (Ig)A, whereas IgG was significantly reduced in H-VSG. Taken together, the quality of milk from H-VSG dams suggests that milk composition could be a factor in reducing the rate of growth during the lactation period.
Keyphrases
- high fat diet
- weight loss
- bariatric surgery
- metabolic syndrome
- minimally invasive
- gestational age
- insulin resistance
- coronary artery bypass
- adipose tissue
- birth weight
- type diabetes
- preterm infants
- preterm birth
- double blind
- skeletal muscle
- blood pressure
- clinical trial
- coronary artery disease
- growth hormone
- atrial fibrillation
- acute coronary syndrome
- case report
- body mass index
- quality improvement